IP Library Granted Patent US 9,580,743
Granted Patent B2
US 9,580,743 · App. 14/450,925 · Granted Feb 28, 2017

SSB-polymerase fusion proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,580,743
App. No.
14/450,925
Granted
Feb 28, 2017
Kind
B2
Abstract

Fusion proteins comprising a single strand DNA binding protein and a nucleic acid polymerase (e.g. DNA polymerase or reverse transcriptase). These high fidelity proteins are suitable for use in nucleic acid amplification methods, including the polymerase chain reaction (PCR).

Claims (19)

1. A method of increasing the yield of a polymerase reaction on a target nucleic acid comprising:

a. contacting said target nucleic acid with a primer which specifically hybridizes thereto, and an isolated or purified fusion protein comprising a single-stranded DNA binding protein (SSB) fused to a nucleic acid polymerase, wherein said SSB comprises amino acids 1 to 150 of SEQ ID NO:2, and wherein the fidelity of said fusion protein is enhanced relative to the fidelity of said nucleic acid polymerase which does not have said SSB fused thereto; and

b. incubating the resulting mixture under conditions whereby said primer is extended by said nucleic acid polymerase.

2. The method of claim 1 , wherein said nucleic acid polymerase comprises amino acids 157 to 929 of SEQ ID NO:2.

3. The method of claim 1 , wherein said fusion protein comprises at least 50% polymerase activity, 3′-5′ exonuclease activity and/or 5′-3′ exonuclease activity of the fusion protein shown in SEQ ID NO:2.

4. The method of claim 1 , wherein said fusion protein comprises the amino acid sequence of SEQ ID NO:2.

5. The method of claim 1 , wherein said nucleic acid polymerase is a DNA polymerase.

6. The method of claim 5 , wherein said DNA polymerase is a thermostable DNA polymerase.

7. The method of claim 6 , wherein said thermostable DNA polymerase is Thermococcus zilligii (Tzi) DNA polymerase.

8. The method of claim 1 , wherein said nucleic acid polymerase is a reverse transcriptase.

9. The method of claim 1 , wherein said fusion protein comprises no detectable endonuclease activity.

10. The method of claim 1 , wherein said fidelity of said fusion protein is enhanced by about 1.2 to 10,000 fold relative to the fidelity of said DNA polymerase which does not have said SSB fused thereto.

11. The method of claim 1 , wherein said SSB is at the N-terminal end and said nucleic acid polymerase is at the C-terminal end of said fusion protein.

12. The method of claim 1 , wherein said SSB and said nucleic acid polymerase are separated by an amino acid linker.

13. The method of claim 12 , wherein said amino acid linker comprises between 1 and 100 amino acids.

14. The method of claim 12 , wherein said amino acid linker comprises the amino acid sequence GSGGVD (Position 151-156 of SEQ ID NO:2).

15. The method of claim 1 , wherein said SSB and said nucleic acid polymerase are immediately adjacent to one another.

16. The method of claim 6 , wherein said thermostable DNA polymerase retains at least 50% of its DNA polymerase activity after being heated at 90° C. for 30 seconds.

17. The method of claim 1 , wherein said fusion protein exhibits a reduced misincorporation rate that is less than 90% of the relative misincorporation rate of said DNA polymerase which does not have said SSB fused thereto.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2016
From: LEE, JUN; POTTER, ROBERT; MANDELMAN, DAVID
To: INVITROGEN CORPORATION
Reel/Frame 040717/0191 →
MERGER Recorded Dec 12, 2016
From: LT NAME CORPORATION; INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 040717/0205 →